Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in...

Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board NEW YORK, March 18, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease...

Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products NEW YORK, March 5, 2015 (GLOBE NEWSWIRE) -- New York-based AXIM Biotechnologies, Inc. (OTC:AXIM) proudly presented its line of the world's first oral care and cosmetic products that include...

AXIM Biotechnologies, Inc. Announces Cosmetics Division NEW YORK, Feb. 19, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and industrial hemp product development, is proud to announce that it has...

AXIM Biotechnologies, Inc. Announces Hemp-Based Oral Care Division NEW YORK, Feb. 12, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and commercial hemp product development, is proud to announce that it is...